HBW Insight

Germany's Supplements Market Boosted By COVID-19

27 Nov 2020

Infographic: COVID-19 delivers an 8% sales growth injection to Germany's supplements market in the first half of the year, accelerating a long-term expansion.

Topic Dietary Supplements Market Intelligence

HBW Insight

Italy's Supplements Market Gets Big Boost From COVID After Solid 2019

By Tom Gallen 15 Jul 2020

Coronavirus pandemic drove up sales of vitamin C supplements and other immunity boosters in Italy in the opening three months of the year.

Topic Coronavirus Dietary Supplements

HBW Insight

No Evidence That Vitamin D Prevents Or Treats COVID-19

By David Ridley 15 Jul 2020

UK's NICE reviews whether Vitamin D can prevent or treat COVID-19, finds evidence wanting.

Topic Coronavirus Dietary Supplements

HBW Insight

Probiotics’ Efficacy Too Specific For General Look In ’60 Minutes’ Segment Critical Of Category

By Eileen Francis 15 Jul 2020

Assertions that no convincing evidence supports that probiotics available in the US treat symptoms of diarrhea, irritable bowel syndrome or allergies look at the category as a whole and not individual strains shown to help with specific conditions, say consumer health industry groups.

Topic Coronavirus Dietary Supplements Research & Development

HBW Insight

US COVID-19 Fraud: Licorice Promoted As Treatment, Unapproved Tests Offered OTC

By Malcolm Spicer 22 Jun 2020

FDA and FTC continue adding to total each has made during novel coronavirus pandemic. FTC's latest include peroxide gel and licorice as treatments; FDA’s emphasizes in warnings that three businesses' tests were not approved for OTC sales or for home use.

Topic Coronavirus Dietary Supplements

HBW Insight

Polish Industry Fighting Against Advertising Tax On Supplements

By Tom Gallen 27 Jan 2020

Advertising dietary supplements in Poland will incur a new tax under proposals from the country's Ministry of Health. While the government claims the motivation is to promote healthy eating choices, industry says supplements have been unfairly linked to poor dietary choices without evidence.

Topic Dietary Supplements

HBW Insight

OTC Zantac And Private Label Ranitidine Numerous In FDA Recall Updates

15 Jan 2020

In addition to Sanofi, firms recalling OTC ranitidine products with documentation included in FDA's database updates through 9 January are Amneal Pharmaceuticals, Preferred Pharmaceuticals, which distributed products made by Amneal, and Granules India Ltd.

Topic Dietary Supplements OTC Drugs Recalls

HBW Insight

Future of CBD In Supplements: NDI Notification Looms As Regulatory Path

By Malcolm Spicer 06 Dec 2019

Recent statement that FDA has not found evidence supporting CBD as GRAS for use in human or animal food potentially points to NDI notifications as the only option manufacturers, marketers and other businesses will have to convince agency about safety for CBD and other hemp-derived substances used in dietary supplements.

Topic Dietary Supplements FDA